Loading stock data…
PGEN
$4.40+0.07 (+1.62%)
Pre-Market$4.45+0.05 (+1.14%)· Last close May 6
Precigen, Inc.,a discovery and clinical-stage biopharmaceutical company, develops gene and cell therapies using precision technology to target diseases in areas of immuno-oncology, autoimmune disorders, and infectious diseases.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Precigen, Inc. in the Healthcare sector is trading at $4.40. The stock is currently 20% below its 52-week high of $5.47, remaining 16.4% above its 200-day moving average. Technical signals show neutral RSI of 68 and bullish MACD crossover, explaining why PGEN maintains its current momentum and trend strength. The Whystock Score of 75/100 reflects a high-conviction bullish alignment.
Ecosystem Influences
Overbought levels (RSI 68) — risk of consolidation or pullback
Long-term trend bullish (Price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Loading Financials...
Peer Comparison
JNJUNHPFE
Whystock Valuation Model
Whystock fair value is estimated using a trailing P/E model adjusted for return on equity: Fair P/E = 18 + (ROE × 20). Fair Value = (Current Price ÷ Trailing P/E) × Fair P/E. A base P/E of 18 represents a typical market multiple, scaled upward for companies that earn high returns on equity. The result is a theoretical "normalised" price — not a price target or investment advice. Large deviations are common for high-growth or loss-making companies.
Current Price$4.40
Potential Upside
5%
Whystock Fair Value$4.62
Price
UndervaluedFair ValueOvervalued
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Fundamentals
Precigen, Inc.,a discovery and clinical-stage biopharmaceutical company, develops gene and cell therapies using precision technology to target diseases in areas of immuno-oncology, autoimmune disorders, and infectious diseases. The company offers the...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$1.40B
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
1.12
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
-1198.61%
Volume
Today's trading volume
3.74M
Recent News
3 Growth Companies With Insider Ownership Up To 15%
Over the last 7 days, the United States market has risen by 1.8%, and over the past 12 months, it has increased by 30%, with earnings forecasted to grow by 16% annually. In this thriving environment, growth companies with high insider ownership can be particularly appealing as they often indicate strong confidence from those closest to the business.
Insider Backed Growth Stocks For Potential Upside
The United States market has experienced a positive trajectory, climbing 1.8% in the last week and rising 30% over the past year, with earnings expected to grow by 16% annually. In this environment, stocks with high insider ownership can be particularly appealing as they often indicate confidence from those who know the company best and may offer potential upside in alignment with broader market growth trends.
High Insider Ownership Growth Stocks To Watch In May 2026
The United States market remained flat over the last week, yet it has experienced a significant 28% rise over the past 12 months with earnings projected to grow by 16% annually. In this environment, growth companies with high insider ownership can be particularly appealing as they often indicate strong confidence from those who know the business best.
Discover 3 Elite Growth Companies With Strong Insider Ownership
In the last week, the United States market has stayed flat, yet over the past 12 months, it has experienced a notable rise of 28%, with earnings forecasted to grow by 16% annually. In this environment, companies that not only demonstrate strong growth potential but also have significant insider ownership can be particularly appealing to investors seeking alignment between management and shareholder interests.
Insiders Favor Cardinal Infrastructure Group And 2 Other Prominent Growth Stocks
Over the last 7 days, the United States market has remained flat, but it has shown a substantial rise of 28% over the past 12 months with earnings forecasted to grow by 16% annually. In this context, growth companies with high insider ownership such as Cardinal Infrastructure Group can be particularly appealing as they often indicate confidence from those closest to the company in its future performance.